Latest News and Press Releases
Want to stay updated on the latest news?
-
IRVINE, Calif. and LUND, Sweden, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) and Siemens Healthineers have signed an agreement that gives CLS the right to license...
-
CERTIFICATE MATURITY190116FIXED RATE-0.25 %OFFERED VOLUME447.000 BLNTOTAL BID AMOUNT390.800 BLNACCEPTED VOLUME 390.800 BLN PERCENTAGE ALLOTTED 100.0000 %NUMBER OF BIDS12 DEPOSIT RATE-1.00...
-
AUCTION DATE:JAN 8, 2019START DATE:JAN 9, 2019MATURITY DATE:JAN 16, 2019NOMINAL AMOUNT:447.0 BLNFIXED RATE:-0.25 % ALL MONETARY POLICY COUNTERPARTIES ARE INVITED TO SUBMIT BIDS TO THE RIKSBANK...
-
HOUSTON, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- CADWorx & Analysis Solutions will host a webinar on January 17, 2019 that will discuss how to use new CADWorx Extended Specifications templates...
-
JAN 07, 2019 SEK MILLION LENDINGBORROWING300 ...
-
Vid SkiStar AB:s årsstämma den 15 december 2018 beslutades om uppdelning av aktier (s.k. aktiesplit) med villkor 2:1. Styrelsen bemyndigades av årsstämman att bestämma avstämningsdag för spliten. ...
-
STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients...
-
STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients...
-
PRESSMEDDELANDE 7 januari 2019 Saniona (OMX: SANION), ett bioteknikföretag med inriktning mot CNS och ätstörningar, meddelar idag att bolaget har slutfört 3-månaders behandlingsperioden av tonåriga...
-
PRESS RELEASE January 7, 2019 Saniona (OMX: SANION), a biotech company focused on CNS and eating disorders, today announced that it has completed the 3-month treatment period in adolescent patients...